Review: In type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA1c without increasing hypoglycemia

Naykky Singh Ospina, Victor M. Montori, R. Retnakaran

Research output: Contribution to journalComment/debatepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Review: In type 2 diabetes, GLP-1 agonists plus basal insulin reduce HbA<sub>1c</sub> without increasing hypoglycemia'. Together they form a unique fingerprint.